)
)
)
SN BioScience Inc.
CLINICAL-STAGE drug development company with innovative drug delivery system targeting ONCOLOGY and METABOLIC(anti-obesity) disease with low development risk and accelerated commercialization potential
SNB-101: WW Market entry in 2028 (SCLC)
Address
SeongnamGyeonggi-do
South Korea
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)